REZZAYO 200 mg/1
rezafungin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Melinta Therapeutics, LLC
REZZAYO is a injection, powder, lyophilized, for solution containing rezafungin at 200 mg/1, taken intravenous. Manufactured by Melinta Therapeutics, LLC.
Key Facts
- Brand Name
- REZZAYO
- Generic Name
- rezafungin
- NDC Code (Product)
70842-240- Manufacturer
- Melinta Therapeutics, LLC
- Strength
- 200 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA217417
- Drug Class
- Echinocandin Antifungal [EPC]
- Marketing Start
- 06/09/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is REZZAYO used for?
REZZAYO contains rezafungin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is REZZAYO a controlled substance?
REZZAYO is not classified as a controlled substance by the DEA.
What is the generic name for REZZAYO?
The generic name for REZZAYO is rezafungin. There are no other listed brand versions of rezafungin.
What is the NDC code for REZZAYO 200 mg/1?
The NDC (National Drug Code) for REZZAYO 200 mg/1 is 70842-240, listed by Melinta Therapeutics, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)